Directors at Sotera Health Sell Over $395M in Stock

Significant insider sales at Sotera Health raise questions amid strong revenue growth and financial risks.

WARBURG PINCUS CO and GTCR INVESTMENT XI LLC, directors at Sotera Health, have sold a combined total of $395.71M in company stock.
The insider sales were disclosed in recent SEC filings, highlighting significant transactions on March 6.
Sotera Health's shares experienced a slight increase, trading at $14.24, following the insider trading news.
The company has shown a notable revenue growth rate of 23.31% as of December 31, 2023, outperforming industry peers.
Despite strong revenue growth, Sotera Health's high debt-to-equity ratio of 5.24 and a P/E ratio of 79.06 suggest potential financial risks.